Blinatumomab

  • 1
  • 2
ATAD00035
-
+
futures
Inquiry
  • Product Details
  • Bioactivity
  • Chemistry
  • How to order
  • Instructions
Catalog No.icon
ATAD00035
INN (International Nonproprietary Name)icon
Blinatumomab
Purityicon
>95%
SDS-PAGE imageicon
    Concentrationicon
    1.42 mg/ml
    Formulationicon
    30 mM histidine pH 5.8,10% sucrose,0.06% Tween 80
    Sourceicon
    CHO cells
    Endotoxin levelicon
    Please contact with the lab for this information.
    Noteicon
    For research use only .
    Descriptionicon
    Blinatumomab is a BiTE-class (bi-specific T-cell engagers) constructed monoclonal antibody indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).Blinatumomab is manufactured by Amgen Inc.and marketed under the brand Blincyto™.Blinatumomab was approved in December 2014 under the FDA’s accelerated approval program,which allows approval of a drug to treat a serious or life-threatening disease based on clinical data showing the drug has an effect on a surrogate endpoint reasonably likely to predict clinical benefit to patients.
    Alternative namesicon
    AMG103,BITE MT-103,MEDI-538,MT103,bscCD19xCD3
    Specificity target name;speciesicon
    CD19/CD3E[Homo sapiens]
    Speciesicon
    Mus musculus
    Receptor identificationicon
    (scFv-kappa-heavy)-(scFv-heavy-kappa)
    MVicon
    54100.00 Da
    CASicon
    853426-35-4
    Storageicon
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    Store at +4°C short term (1-2 weeks).
    Store at -20 °C 12 months.
    Store at -80°C long term.

    Guarantee and Disclaimer:

    After receiving the product, if finds that the product is mismatched, damaged or missing components, please keep the original package and submit the objection to the company by mail within seven working days. Failure to file an objection within the time limit is considered qualified.

    When the buyer keeps the product, it should be kept in accordance with the storage conditions shown in the product label and the manual. If the product quality is caused by improper storage, it will not be guaranteed.

    When the buyer tests the product, they should be submitted by the beginning of use when found the quality issue, rather than when the product was used or used up, in order to prepare our products for recycling and confirm the quality of the products. If it is the quality problem, our company is responsible for exchange or return. In the event of a claim, our company will compensate the discretion within the scope of the product price limit and will not accept any part of the value of the product itself. Since the date of receipt, the product has not been reflected for more than three months and should not be returned.

    The products provided by our company are for research use only and should not be used for clinical diagnosis or treatment. If a unit or individual changes the use of our products without authorization, we will not bear any responsibility.